Dr. Allende is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7 Metropolitan Ct
Ste 1
Gaithersburg, MD 20878Phone+1 240-773-0300
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1999 - 2001
- George Washington UniversityResidency, Internal Medicine, 1994 - 1996
- George Washington UniversityInternship, Internal Medicine, 1993 - 1994
- National Cancer InstituteFellowship, Infections of The Immunocompromised Host, 1990 - 1993
- University of Buenos AiresClass of 1982
Certifications & Licensure
- MD State Medical License 2011 - 2026
- VA State Medical License 1996 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Study To Evaluate the Safety of Bivalent Vaccine Start of enrollment: 2006 Jun 01
Publications & Presentations
PubMed
- 113 citationsSafety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.Constantino López-Macías, Eduardo Ferat-Osorio, Alejandra Tenorio-Calvo, Armando Isibasi, Juan O Talavera
Vaccine. 2011-10-13 - 68 citationsShedding of Live Vaccine Virus, Comparative Safety, and Influenza-Specific Antibody Responses after Administration of Live Attenuated and Inactivated Trivalent Influen...Myron J. Levin, Lin-Ye Song, Terrence Fenton, Sharon Nachman, Julie Patterson
Vaccine. 2008-08-05 - 31 citationsAnti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children.Adriana Weinberg, Lin-Ye Song, Robert E. Walker, Maria Allende, Terence Fenton
Journal of Acquired Immune Deficiency Syndromes. 2010-10-01
Press Mentions
- J&J Adcomm Live Blog: Will Variants Impede a Long-Sought Goal for Covid-19 Research?February 26th, 2021
- J&J Adcomm Live Blog: Committee Votes 22-0 to Recommend an FDA OK for the J&J Vaccine, Setting up 3rd US Covid-19 JabFebruary 26th, 2021
Professional Memberships
- Infectious Diseases Society of AmericaMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: